Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s Day in Review: Closing at 18.13, Down by -0.77

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $18.27 in the prior trading day, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed at $18.13, down -0.77%. In other words, the price has decreased by -$0.77 from its previous closing price. On the day, 4.64 million shares were traded. TEVA stock price reached its highest trading level at $18.39 during the session, while it also had its lowest trading level at $18.1211.

Ratios:

Our goal is to gain a better understanding of TEVA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.90. For the most recent quarter (mrq), Quick Ratio is recorded 0.59 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 2.98 whereas as Long-Term Debt/Eq ratio is at 2.65.

On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.

Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’24 when Daniell Richard sold 98,943 shares for $17.30 per share. The transaction valued at 1,711,447 led to the insider holds 0 shares of the business.

Grant Angus sold 4,065 shares of TEVA for $70,243 on Aug 09 ’24. The EVP, Business Development now owns 8,848 shares after completing the transaction at $17.28 per share. On Aug 09 ’24, another insider, Hughes Eric A, who serves as the See “Remarks” of the company, sold 45,060 shares for $17.38 each. As a result, the insider received 782,972 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 20852217856 and an Enterprise Value of 37407637504. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.26 while its Price-to-Book (P/B) ratio in mrq is 3.23. Its current Enterprise Value per Revenue stands at 2.296 whereas that against EBITDA is 8.194.

Stock Price History:

Over the past 52 weeks, TEVA has reached a high of $18.58, while it has fallen to a 52-week low of $8.06. The 50-Day Moving Average of the stock is 6.84%, while the 200-Day Moving Average is calculated to be 32.39%.

Shares Statistics:

The stock has traded on average 9.19M shares per day over the past 3-months and 7675070 shares per day over the last 10 days, according to various share statistics. A total of 1.13B shares are outstanding, with a floating share count of 1.13B. Insiders hold about 0.10% of the company’s shares, while institutions hold 55.00% stake in the company. Shares short for TEVA as of 1722384000 were 19500767 with a Short Ratio of 2.12, compared to 1719532800 on 22312625. Therefore, it implies a Short% of Shares Outstanding of 19500767 and a Short% of Float of 1.73.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 2.95.

Most Popular